Literature DB >> 14670301

Activation of autoreactive B cells by CpG dsDNA.

Gregory A Viglianti1, Christina M Lau, Timothy M Hanley, Benjamin A Miko, Mark J Shlomchik, Ann Marshak-Rothstein.   

Abstract

The proliferative response of autoreactive rheumatoid factor (RF) B cells to mammalian chromatin-containing immune complexes (ICs) results from the sequential engagement of the B cell receptor (BCR) and Toll-like receptor 9 (TLR9). We have used ICs constructed from anti-hapten antibodies and defined haptenated dsDNA fragments to determine the form of mammalian DNA that mediates this process. Despite their relatively low abundance in mammalian DNA, we found that inclusion of hypomethylated CpG motifs in these ICs was necessary for effective activation. In the absence of antibody, the same fragments could efficiently stimulate low-affinity hapten-specific and DNA-reactive 3H9 B cells, but not RF B cells. These results extend the BCR/TLR9 coengagement paradigm to a second major class of autoreactive B cells, further confirm the critical role of the BCR in chromatin ligand delivery to TLR9, and implicate hypomethylated CpG motifs as ligand elements necessary for the initiation of systemic autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670301     DOI: 10.1016/s1074-7613(03)00323-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  166 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  TLR7: A new sensor of viral infection.

Authors:  K Crozat; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-27       Impact factor: 11.205

3.  TLR9 is localized in the endoplasmic reticulum prior to stimulation.

Authors:  Cynthia A Leifer; Margaret N Kennedy; Alessandra Mazzoni; ChangWoo Lee; Michael J Kruhlak; David M Segal
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 4.  Regulation of B-cell responses by Toll-like receptors.

Authors:  Edward P Browne
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 5.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 6.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

Review 7.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

8.  GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.

Authors:  Balaji B Ganesh; Donald M Cheatem; Jian Rong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Int Immunol       Date:  2009-01-27       Impact factor: 4.823

9.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

10.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation.

Authors:  Jonathan A Deane; Prapaporn Pisitkun; Rebecca S Barrett; Lionel Feigenbaum; Terrence Town; Jerrold M Ward; Richard A Flavell; Silvia Bolland
Journal:  Immunity       Date:  2007-11-08       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.